Oncotest- CRO in Preclinical Cancer Research Using Patient Derived Tumor Xenograft (PDX) models| gastric cancer, breast cancer, small cell lung cancer, pancreatic cancer, melanoma, leukemia - Oncotest
Using patient derived tumor xenograft (PDX) models, Oncotest as a CRO provides tailored preclinical solutions for the identification of the best anti-cancer drug candidates, target validation, and in-depth bioinformatics analyses.
cancer, tumor models, patient derived xenograft, preclinical oncology, in vivo studies, pdx, oncotest
Est-ce votre site ? Validez et mettez à jour les informations de votre site
